Enoxaparin is a cost-effective adjunct to fibrinolytic therapy for ST-elevation myocardial infarction in contemporary practice

Verfasser / Beitragende:
[Ian Menown, Gilles Montalescot, Nikhal Pal, Carrie Fidler, Michelle Orme, Samantha Gillard]
Ort, Verlag, Jahr:
2010
Enthalten in:
Advances in Therapy, 27/3(2010-03-01), 181-191
Format:
Artikel (online)
ID: 445091886